Close Menu

NEW YORK – PerkinElmer reported after the close of the market on Monday that its revenues in the fourth quarter of 2019 rose almost 7 percent year over year.

For the three months ended Dec. 29, 2019, the Waltham, Massachusetts-based company said total revenues increased to $805.5 million compared to $756.3 million a year ago. It beat analysts' average estimate of $800.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.